Elek­trofi, a start­up that helps drug­mak­ers for­mu­late bi­o­log­ics for eas­i­er de­liv­ery, is rais­ing a $112M Se­ries C

Bi­o­log­ics start­up Elek­trofi is rais­ing an ap­prox­i­mate­ly $112 mil­lion Se­ries C, CEO and co-founder Chase Coff­man con­firmed to End­points News.

The Boston-based start­up works with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER